Fibrin Peptide Fails Reperfusion Injury Test, University of Oslo Study
MedPage -- Reperfusion injury was only minimally less when patients received an investigational fibrin derivative during percutaneous coronary intervention following myocardial infarction, according to results of a multinational European trial.